Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity
International Journal of Nanomedicine · 2025-02 · Volume 20 · 2087-2101
DOI: 10.2147/ijn.s500999 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025-02. Verfasst von Didi Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, People's Republic of China. Hauptthemen laut MEDLINE: Paclitaxel, Glucose, Prodrugs, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Paclitaxel-induced blood system disorders and peripheral neuropathy impede the progress of new formulations in clinical trials. Purpose of Study: To mitigate these adverse effects by developing and validating a prodrug strategy that encapsulates a glucose-paclitaxel conjugate within nanomicelles. Material and Methods: Succinic anhydride was used as a bridge to couple C2'-paclitaxel with methyl 2'-glucopyranose and prepare a glucose-paclitaxel conjugate. Nanomicelles were prepared via solid-phase dispersion, and dynamic light scattering was used to determine their average diameter and the polydispersity index. High-performance liquid chromatography (HPLC) was employed to evaluate drug-loading capacity and encapsulation efficiency. Pharmacokinetic studies and in vivo toxicity assays were performed in Sprague-Dawley (SD) rats.
Results
The nanomicellar product exhibited a spherical shape with a particle size distribution between 20-60 nm, a PDI of 0.26 ± 0.01, and an encapsulation efficiency of 95.59 ± 1.73%. The pharmacokinetic profile of glucose-paclitaxel nanomicelles in SD rats was markedly different from that of the paclitaxel solution group. Notably, the plasma drug concentration of glucose-paclitaxel nanomicelles was significantly higher than the paclitaxel solution 15 minutes post-administration, with a Vz at only 40% of that of the paclitaxel solution, while the AUC0-∞ was five times greater than that of the paclitaxel solution. Ultimately, glucose-paclitaxel nanomicelles effectively alleviated blood system disorders and peripheral neuropathy in SD rats.
Conclusion
The encapsulation of glucose-paclitaxel conjugates within nanomicelles presents a viable solution to the dose-limiting toxicities associated with paclitaxel, offering new perspectives on safety for the development of paclitaxel-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, 050018, People's Republic of China.
- Department of Psychiatry, Fundamental and Clinical Research on Mental Disorders Key Laboratory of Luzhou, Affiliated Hospital of Southwest Medical University, Luzhou, 646000, People's Republic of China.
- New Drug Research & Development Co., Ltd., North China Pharmaceutical Group Corporation, Shijiazhuang, 050015, People's Republic of China.
- Hebei Research Center of Pharmaceutical and Chemical Engineering, Shijiazhuang, 050018, People's Republic of China.
Zitieren
APA
Yan, D., Ma, X., Hu, Y., Zhang, G., Hu, B., Xiang, B., Cheng, X., Jing, Y., & Chen, X. (2025). Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity. International Journal of Nanomedicine, Volume 20, 2087-2101. https://doi.org/10.2147/ijn.s500999
Vancouver
Yan D, Ma X, Hu Y, Zhang G, Hu B, Xiang B, et al. Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity. International Journal of Nanomedicine. 2025;Volume 20:2087-2101. doi:10.2147/ijn.s500999
BibTeX
@article{Yan2025,
author = {Yan, Didi and Ma, Xinyue and Hu, Yixin and Zhang, Guogang and Hu, Beibei and Xiang, Bo and Cheng, Xiaokun and Jing, Yongshuai and Chen, Xi},
title = {Nanomicellar Prodrug Delivery of Glucose-Paclitaxel: A Strategy to Mitigate Paclitaxel Toxicity},
journal = {International Journal of Nanomedicine},
year = {2025},
volume = {Volume 20},
pages = {2087--2101},
doi = {10.2147/ijn.s500999}
}
EUVIMED